Clinical Trials
472 trialsConcordance Between Large Language Model and Multidisciplinary Team Recommendations in Rectal Cancer
Shandong Cancer Hospital and Institute
STEP-R
Gazi University
OvAR-Y
Washington University School of Medicine
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
Eastern Cooperative Oncology Group
GEORGIA
Ohio State University Comprehensive Cancer Center
LUMEVAL
Bordeaux Colorectal Institute Academy
Exosomes in Rectal Cancer
University of Kansas Medical Center
iCaRe2
University of Nebraska
PRESERVE
Insel Gruppe AG, University Hospital Bern
RC-NAT-RWS
Beijing Friendship Hospital
Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Shandong Cancer Hospital and Institute
ACROBATICC
Helse Stavanger HF
RAPIDO
Sengkang General Hospital
DEMETRA
San Raffaele University
DLARC
Sixth Affiliated Hospital, Sun Yat-sen University
ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer
Massachusetts General Hospital
A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI
Sixth Affiliated Hospital, Sun Yat-sen University
Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer
Mayo Clinic
ctDNA-MRD-RC
Beijing Friendship Hospital
Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in the Follow up of Patients With Colorectal Carcinoma.
Assiut University
Young-Onset Colorectal Cancer
M.D. Anderson Cancer Center
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
Chang Gung Memorial Hospital
ANGIOPREDICT. ICORG 12-16, V3
Cancer Trials Ireland
RESTAGE
Institut du Cancer de Montpellier - Val d'Aurelle
Registry Maastro Applicator
Maastricht Radiation Oncology
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Case Comprehensive Cancer Center
Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
M.D. Anderson Cancer Center
Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning
Peking University People's Hospital
Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients
Mersin University
Changes of Low Anterior Resection Syndrome and Balance Ability in Patients With Rectal Cancer.
Chang Gung Memorial Hospital
Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer
Consorci Sanitari de Terrassa
Neo-Flo-Rect
Centre Oscar Lambret
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Memorial Sloan Kettering Cancer Center
SYNCHRONOX
Assistance Publique - Hôpitaux de Paris
Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer
M.D. Anderson Cancer Center
MOMENTUM
UMC Utrecht
COLBRAIN
Blokhin's Russian Cancer Research Center
FAMCAP
Hôpital Edouard Herriot
Relationship Between Quality of Life, Treatment Modalities, and Patient Treatment/Outcome Expectations
M.D. Anderson Cancer Center
MRA Diameter as a Predictor for LLN Metastasis in Rectal Cancer.
First Affiliated Hospital of Fujian Medical University
Advanced Endoscopic Resections for Rectal Neoplasms
Jagiellonian University
SNOWW
University of Colorado, Denver
PROS-PE
Chang Gung Memorial Hospital
R-ALERT
University of Edinburgh
ENCODE
City of Hope Medical Center
Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma
Sohag University
NOSE
Istituto Clinico Humanitas
Exploring the Predictive Effect of Intestinal and Oral Microbiota on the Efficacy of Neoadjuvant Radiotherapy and Chemotherapy for Locally Advanced Rectal Cancer Based on Machine Learning
Nanfang Hospital, Southern Medical University
SCORE
Natera, Inc.